212 related articles for article (PubMed ID: 37128730)
21. Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine.
Hong X; Wei L; Wu F; Wu Z; Chen L; Liu Z; Yuan W
Drug Des Devel Ther; 2013; 7():945-52. PubMed ID: 24039404
[TBL] [Abstract][Full Text] [Related]
22. Finite element analysis and optimization of microneedle arrays for transdermal vaccine delivery: comparison of coated and dissolving microneedles.
Yolai N; Suttirat P; Leelawattanachai J; Boonyasiriwat C; Modchang C
Comput Methods Biomech Biomed Engin; 2023 Sep; 26(12):1379-1387. PubMed ID: 36048187
[TBL] [Abstract][Full Text] [Related]
23. A key role by polymers in microneedle technology: a new era.
Rajput A; Kulkarni M; Deshmukh P; Pingale P; Garkal A; Gandhi S; Butani S
Drug Dev Ind Pharm; 2021 Nov; 47(11):1713-1732. PubMed ID: 35332822
[TBL] [Abstract][Full Text] [Related]
24. Microneedle delivery: clinical studies and emerging medical applications.
Pettis RJ; Harvey AJ
Ther Deliv; 2012 Mar; 3(3):357-71. PubMed ID: 22833995
[TBL] [Abstract][Full Text] [Related]
25. Separable Microneedle Patch to Protect and Deliver DNA Nanovaccines Against COVID-19.
Yin Y; Su W; Zhang J; Huang W; Li X; Ma H; Tan M; Song H; Cao G; Yu S; Yu D; Jeong JH; Zhao X; Li H; Nie G; Wang H
ACS Nano; 2021 Sep; 15(9):14347-14359. PubMed ID: 34472328
[TBL] [Abstract][Full Text] [Related]
26. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
27. Microneedle-based vaccines.
Prausnitz MR; Mikszta JA; Cormier M; Andrianov AK
Curr Top Microbiol Immunol; 2009; 333():369-93. PubMed ID: 19768415
[TBL] [Abstract][Full Text] [Related]
28. Intradermal and transdermal drug delivery using microneedles - Fabrication, performance evaluation and application to lymphatic delivery.
Sabri AH; Kim Y; Marlow M; Scurr DJ; Segal J; Banga AK; Kagan L; Lee JB
Adv Drug Deliv Rev; 2020 Jan; 153():195-215. PubMed ID: 31634516
[TBL] [Abstract][Full Text] [Related]
29. Transdermal Insulin Delivery and Microneedles-based Minimally Invasive Delivery Systems.
Hong Y; Yu H; Wang L; Chen X; Huang Y; Yang J; Ren S
Curr Pharm Des; 2022; 28(39):3175-3193. PubMed ID: 35676840
[TBL] [Abstract][Full Text] [Related]
30. Parameter optimization toward optimal microneedle-based dermal vaccination.
van der Maaden K; Varypataki EM; Yu H; Romeijn S; Jiskoot W; Bouwstra J
Eur J Pharm Sci; 2014 Nov; 64():18-25. PubMed ID: 25151530
[TBL] [Abstract][Full Text] [Related]
31. Microneedles for drug delivery: recent advances in materials and geometry for preclinical and clinical studies.
Kang NW; Kim S; Lee JY; Kim KT; Choi Y; Oh Y; Kim J; Kim DD; Park JH
Expert Opin Drug Deliv; 2021 Jul; 18(7):929-947. PubMed ID: 32975144
[TBL] [Abstract][Full Text] [Related]
32. Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin.
Prausnitz MR
Annu Rev Chem Biomol Eng; 2017 Jun; 8():177-200. PubMed ID: 28375775
[TBL] [Abstract][Full Text] [Related]
33. Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination.
McCrudden MT; Torrisi BM; Al-Zahrani S; McCrudden CM; Zaric M; Scott CJ; Kissenpfennig A; McCarthy HO; Donnelly RF
J Pharm Pharmacol; 2015 Mar; 67(3):409-25. PubMed ID: 24673568
[TBL] [Abstract][Full Text] [Related]
34. Structural analysis and simulation of solid microneedle array for vaccine delivery applications.
S B V J C; Mannayee G
Mater Today Proc; 2022; 65():3774-3779. PubMed ID: 35855948
[TBL] [Abstract][Full Text] [Related]
35. Smart Mushroom-Inspired Imprintable and Lightly Detachable (MILD) Microneedle Patterns for Effective COVID-19 Vaccination and Decentralized Information Storage.
Li Q; Xu R; Fan H; Xu J; Xu Y; Cao P; Zhang Y; Liang T; Zhang Y; Chen W; Wang Z; Wang L; Chen X
ACS Nano; 2022 May; 16(5):7512-7524. PubMed ID: 35451839
[TBL] [Abstract][Full Text] [Related]
36. Dissolving Microneedle Arrays for Transdermal Delivery of Amphiphilic Vaccines.
An M; Liu H
Small; 2017 Jul; 13(26):. PubMed ID: 28544329
[TBL] [Abstract][Full Text] [Related]
37. Rabies vaccination in dogs using a dissolving microneedle patch.
Arya JM; Dewitt K; Scott-Garrard M; Chiang YW; Prausnitz MR
J Control Release; 2016 Oct; 239():19-26. PubMed ID: 27524283
[TBL] [Abstract][Full Text] [Related]
38. Safety and dose-sparing effect of Japanese encephalitis vaccine administered by microneedle patch in uninfected, healthy adults (MNA-J): a randomised, partly blinded, active-controlled, phase 1 trial.
Iwata H; Kakita K; Imafuku K; Takashima S; Haga N; Yamaguchi Y; Taguchi K; Oyamada T
Lancet Microbe; 2022 Feb; 3(2):e96-e104. PubMed ID: 35544051
[TBL] [Abstract][Full Text] [Related]
39. Microneedle patches for vaccination in developing countries.
Arya J; Prausnitz MR
J Control Release; 2016 Oct; 240():135-141. PubMed ID: 26603347
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of efficacy and safety of intradermal delivery of vaccines through microneedle(s) in human beings: a protocol for a systematic review.
Bajwa IK; Kaur N; Dsouza JM; Mathew JL
Syst Rev; 2022 Aug; 11(1):170. PubMed ID: 35964062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
